GAO spotlights FDA’s COVID-related drug inspection backlog

Researcher using biosafety cabinet
Mar 05, 2021

GAO emphasizes addressing the backlog, pre-announced inspections, and alternative approaches.

Lianna Matt McLernon | News Writer | CIDRAP News

Mar 05, 2021
GAO emphasizes addressing the backlog, pre-announced inspections, and alternative approaches.Read More

Leave a Reply

Your email address will not be published.